Related Experiment Video
Updated: Feb 14, 2026

Analysis of Oxidative Stress in Zebrafish Embryos
Published on: July 7, 2014
Implication of xanthine oxidoreductase in oxidative stress-related chronic diseases
Kendra L Nelson1,2, Venkata Saroja Voruganti1,2
1Department of Nutrition, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
Abstract:
Xanthine oxidoreductase (XOR) catalyzes the final steps of purine catabolism: the oxidation of hypoxanthine to xanthine, and xanthine to UA. XOR exists as interconvertible proteoforms, xanthine dehydrogenase (XDH) and xanthine oxidase (XO). The balance between XDH and XO determines whether purine degradation is redox-neutral or strongly pro-oxidant. Evidence across cardiovascular, renal, oncological and neurological disorders shows that excess XO-derived ROS, rather than UA itself, is a likely mediator of tissue injury and clinical progression, with several lines of research linking them to the interplay between XOR and purinergic signaling. Pharmacological inhibition or down-regulation of XO ameliorates pathology even when UA concentrations remain unchanged, underscoring the therapeutic relevance of the proteoform-specific mechanism. This mini-review focuses on the structure, regulation, and pathological roles of XOR, with emphasis on its implications in oxidative stress-related diseases.
Related Concept Videos
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Kidney Disease I: Introduction
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Kidney Disease II: Clinical Manifestations
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation

